$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference
08:05pm, Monday, 22'nd Aug 2022 GlobeNewswire Inc.
Kalamazoo, Michigan, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022.
Why This Dividend Stock Is a Buy
01:40pm, Thursday, 18'th Aug 2022 The Motley Fool
Stryker's medical devices reach more than 100 million patients each year.
Why This Dividend Stock Is a Buy
09:40am, Thursday, 18'th Aug 2022
Stryker's medical devices reach more than 100 million patients each year.
Should You Really Care About This Company's Short-Term Success?
10:00am, Friday, 05'th Aug 2022 The Motley Fool
Abbott Laboratories' growth looks much less impressive after removing sales from COVID-19 diagnostics.
Should You Really Care About This Company's Short-Term Success?
06:00am, Friday, 05'th Aug 2022
Abbott Laboratories' growth looks much less impressive after removing sales from COVID-19 diagnostics.
Stryker Is A Moat-Worthy Buy, Here's Why
08:15am, Wednesday, 03'rd Aug 2022
Stryker is a diversified medical technology company with strong sales growth, profitability, and a long history of dividend growth. It's well positioned to invest in strategic growth areas and benefit
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022
02:07pm, Thursday, 28'th Jul 2022 Benzinga
Upgrades
According to Argus Research, the prior rating for Huntington Bancshares Inc (NASDAQ:HBAN) was changed from Hold to Buy. In the second quarter, Huntington Bancshares showed an EPS of $0.36, c
Stryker's (SYK) Q2 Earnings and Revenues Miss Estimates
02:04pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Stryker's (SYK) second-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurt sales growth.
Where Stryker Stands With Analysts
01:17pm, Wednesday, 27'th Jul 2022 Benzinga
Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
4
4
0
0
Last 30D
0
Walmart To $142? Plus This Analyst Raises Price Target On McDonald's
01:01pm, Wednesday, 27'th Jul 2022 Benzinga
Keybanc raised the price target for McDonald's Corporation (NYSE: MCD) from $285 to $290. However, Keybanc analyst Eric Gonzalez maintained the stock with an Overweight rating. McDonald's shares fel
Stryker (SYK) Lags Q2 Earnings and Revenue Estimates
10:25pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Stryker (SYK) delivered earnings and revenue surprises of -0.88% and 0.78%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Stryker Corporation (SYK) CEO Kevin Lobo on Q2 2022 Results - Earnings Call Transcript
10:12pm, Tuesday, 26'th Jul 2022
Stryker Corporation (NYSE:SYK ) Q2 2022 Earnings Conference Call July 26, 2022 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Glenn Boehnlein - Chief Financial Officer
Stryker (SYK) Lags Q2 Earnings and Revenue Estimates
08:12pm, Tuesday, 26'th Jul 2022
Stryker (SYK) delivered earnings and revenue surprises of -0.88% and 0.78%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
How Medtronic Is Strengthening Its Robotics Portfolio
02:37pm, Sunday, 24'th Jul 2022 The Motley Fool
Advanced technology in spinal surgery is helping the company build its case in a fast-growing market.
Dividend Champion, Contender, And Challenger Highlights: Week Of July 24
04:22am, Sunday, 24'th Jul 2022 Seeking Alpha
Click here to read the summary of dividend activity for Dividend Champions, Contenders, and Challengers for the week of July 24.
Sign In
Buy SYK